Share on StockTwits

Examworks Group (NASDAQ:EXAM) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued on Tuesday. They currently have a $38.30 price objective on the stock. Zacks‘s target price suggests a potential upside of 14.19% from the company’s current price.

A number of other firms have also recently commented on EXAM. Analysts at Needham & Company LLC raised their price target on shares of Examworks Group from $38.00 to $42.00 in a research note on Thursday, July 31st. Separately, analysts at Credit Suisse reiterated an “outperform” rating on shares of Examworks Group in a research note on Wednesday, July 30th. They now have a $42.00 price target on the stock, up previously from $41.00. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Examworks Group in a research note on Wednesday, July 30th. They now have a $45.00 price target on the stock, up previously from $40.00.

Examworks Group (NASDAQ:EXAM) traded up 1.01% during mid-day trading on Tuesday, hitting $33.88. The stock had a trading volume of 140,487 shares. Examworks Group has a 52 week low of $22.22 and a 52 week high of $38.61. The stock has a 50-day moving average of $32.59 and a 200-day moving average of $32.89. The company’s market cap is $1.331 billion.

Examworks Group (NASDAQ:EXAM) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.05. The company had revenue of $196.45 million for the quarter, compared to the consensus estimate of $184.52 million. During the same quarter in the previous year, the company posted ($0.08) earnings per share. The company’s revenue for the quarter was up 25.8% on a year-over-year basis. Analysts expect that Examworks Group will post $0.19 EPS for the current fiscal year.

ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.